Research

Hormonal

Administration of ursodeoxycholic acid (UDCA) attenuates high-fat diet-induced obesity in mice by increasing hepatic levels of non-12-hydroxylated bile acids (non-12-OH BAs), which enhances GLP-1 secretion and upregulates UCP1 and PGC1a in brown adipose tissue.

This research suggests that ursodeoxycholic acid (UDCA) may help prevent obesity in the context of a high-fat diet by boosting beneficial bile acids (non-12-OH BAs). These bile acids signal the body to burn more energy (via UCP1 in fat tissue) and release satiety hormones (GLP-1). While this is a promising therapeutic avenue, it is currently based on animal models. For humans, maintaining a healthy weight through diet and exercise remains the primary strategy, but this mechanism highlights why bile acid health is important for metabolic function.

ModerateSupportsMEDIUM confidence
In addition, we identified that UDCA attenuated the high fat diet-induced obesity via enhancing levels of non-12-OH BAs.
Meilin Wei et al. · EBioMedicine · 2020

Why this rating

The study uses a robust animal model (HF-OP/HF-OR mice) with multiple validation methods (metabolomics, transcriptomics, histology), but results are not directly translatable to humans without further clinical trials.

Source

A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility

Meilin Wei et al. · EBioMedicine · 2020

DOI 10.1016/j.ebiom.2020.102766

cross_sectional · n=183Cited 239×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →